121 related articles for article (PubMed ID: 1521670)
1. Multicentre clinical placebo-controlled study with buflomedil in the treatment of mild dementia of vascular origin.
Cucinotta D; Aveni Casucci MA; Pedrazzi F; Ponari O; Capodaglio M; Valdina P; Toxiri I; Bartorelli L; Granata Q; Franzini C
J Int Med Res; 1992 Apr; 20(2):136-49. PubMed ID: 1521670
[TBL] [Abstract][Full Text] [Related]
2. Effect of buflomedil on behaviour, memory, and intellectual capacity in patients with dementia. A placebo-controlled study.
Levinson B; Wright P; Barklem S
S Afr Med J; 1985 Aug; 68(5):302-7. PubMed ID: 3898413
[TBL] [Abstract][Full Text] [Related]
3. Buflomedil in arterial occlusive disease: results of a controlled multicenter study.
Trübestein G; Balzer K; Bisler H; Klüken N; Muller-Wiefel H; Unkel B; Mahfoud Y; Ziegler W
Angiology; 1984 Aug; 35(8):500-5. PubMed ID: 6383127
[TBL] [Abstract][Full Text] [Related]
4. Buflomedil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in peripheral and cerebral vascular diseases.
Clissold SP; Lynch S; Sorkin EM
Drugs; 1987 May; 33(5):430-60. PubMed ID: 3297620
[TBL] [Abstract][Full Text] [Related]
5. A review of long-term safety data with buflomedil.
Bachand RT; Dubourg AY
J Int Med Res; 1990; 18(3):245-52. PubMed ID: 2193838
[TBL] [Abstract][Full Text] [Related]
6. Encephalotropic and psychotropic effects of intravenous buflomedil in the elderly: double-blind, placebo-controlled pharmaco-EEG and psychometric studies.
Saletu B; Grünberger J; Linzmayer L; Stöhr H
Int J Clin Pharmacol Res; 1984; 4(2):95-107. PubMed ID: 6469443
[TBL] [Abstract][Full Text] [Related]
7. A placebo-controlled study of the effects of intravenous Buflomedil on foot skin microcirculation in patients with severe intermittent claudication.
Van den Brande P; Maurel A
Angiology; 1998 Feb; 49(2):105-14. PubMed ID: 9482510
[TBL] [Abstract][Full Text] [Related]
8. Double-blind placebo-controlled trial of buflomedil in the treatment of Raynaud's phenomenon: six-month follow-up.
Le Quentrec P; Lefebvre ML
Angiology; 1991 Apr; 42(4):289-95. PubMed ID: 1673051
[TBL] [Abstract][Full Text] [Related]
9. Effect of long-term administration of buflomedil on regional cerebral blood flow in chronic cerebral infarction.
Kobayashi S; Yamaguchi S; Okada K; Kitani M; Yamashita K; Shimote K; Tsunematsu T
Angiology; 1988 Nov; 39(11):934-41. PubMed ID: 3177960
[TBL] [Abstract][Full Text] [Related]
10. [Effect of buflomedil perfusion on peripheral tissue oxygenation during transluminal angioplasty in patients with advanced arteriopathy of the lower limbs].
Joffre F; Meites G; Rousseau H; Staffin C; Allaert FA; Pelat P
Ann Radiol (Paris); 1994; 37(3):239-44. PubMed ID: 8092756
[TBL] [Abstract][Full Text] [Related]
11. The pharmacological effects of buflomedil in patients with multi-cerebral infarcts dementia: an open, preliminary assessment.
Karoutas G; Milonas I; Artemis N; Karacostas D; Pitas J; Logothetis J
Curr Med Res Opin; 1987; 10(6):380-9. PubMed ID: 3568750
[TBL] [Abstract][Full Text] [Related]
12. Improvement of microcirculation abnormalities in sickle cell patients upon buflomedil treatment.
Bachir D; Maurel A; Beuzard Y; Razavian M; Kraiem A; Portos JL; Galacteros F
Microvasc Res; 1993 Nov; 46(3):359-73. PubMed ID: 8121319
[TBL] [Abstract][Full Text] [Related]
13. Clinical and hemorheological effects of buflomedil in diabetic subjects with intermittent claudication.
Diamantopoulos EJ; Grigoriadou M; Ifanti G; Raptis SA
Int Angiol; 2001 Dec; 20(4):337-44. PubMed ID: 11782701
[TBL] [Abstract][Full Text] [Related]
14. A meta-analysis of randomized, double-blind, placebo-controlled studies of the effect of buflomedil on intermittent claudication.
Walker GA; Mac Hannaford JC
Fundam Clin Pharmacol; 1995; 9(4):387-94. PubMed ID: 8566940
[TBL] [Abstract][Full Text] [Related]
15. Oral buflomedil in the prevention of cardiovascular events in patients with peripheral arterial obstructive disease: a randomized, placebo-controlled, 4-year study.
; Leizorovicz A; Becker F
Circulation; 2008 Feb; 117(6):816-22. PubMed ID: 18212283
[TBL] [Abstract][Full Text] [Related]
16. The treatment of senile dementia associated with cerebrovascular insufficiency: a comparative study of buflomedil and dihydrogenated ergot alkaloids.
Jansen W; Bruckner GW; Jansen P
J Int Med Res; 1985; 13(1):48-53. PubMed ID: 3884411
[TBL] [Abstract][Full Text] [Related]
17. Oral buflomedil in diabetic background retinopathy: results of a preliminary controlled study.
Ducrey N; Curchod B
J Int Med Res; 1984; 12(3):184-7. PubMed ID: 6734921
[TBL] [Abstract][Full Text] [Related]
18. [Effects of buflomedil on survival rate, local cerebral blood flow and glucose utilization after cerebral ischemia in spontaneously hypertensive rats].
Ishikawa T; Sano T; Kuroda Y; Soejima Y; Maekawa T; Sakabe T; Takeshita H
Nihon Yakurigaku Zasshi; 1987 Dec; 90(6):303-12. PubMed ID: 3443412
[TBL] [Abstract][Full Text] [Related]
19. [Action of Buflomedil on the cutaneous microcirculation studies by a cold provocation test. Multicenter, double-blind, placebo controlled trial].
Maurel A; Betrancourt JC; Van Frenkel R; Thuillez C
J Mal Vasc; 1995; 20(2):127-33. PubMed ID: 7650439
[TBL] [Abstract][Full Text] [Related]
20. Effects of buflomedil in a group of patients with chronic peripheral arterial diseases. Clinical and hemorheological evaluation.
Mozzi E; Chiurazzi D; Spinola A; Annoni F; Germiniani R
J Int Med Res; 1985; 13(6):317-21. PubMed ID: 4076530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
